SEARCH

SEARCH BY CITATION

References

  • Adell, A. & Artigas, F. (1991). Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxy-tryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn-Schmiedeberg' s Arch. Pharmacol., 343, 237244.
  • Adell, A., Carceller, A. & Artigas, F. (1993). In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylami-no)tetralin. J. Neurochem., 60, 16731681.
  • Adell, A., Casanovas, J.M. & Artigas, F. (1997). Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology, 36, 735741.
  • Adell, A., Sarna, G.S., Hutson, P.H. & Curzon, G. (1989). An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats. Br. J. Pharmacol., 97, 206212.
  • Arborelius, L., Nomikos, G.G., Grillner, P., Hertel, P., Höök, B.B., Hacksell, U. & Svensson, T.H. (1995). 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rat treated acutely or chronically with citalopram. Naunyn-Schmiedeberg' s Arch. Pharmacol., 352, 157165.
  • Assié, M.-B. & Koek, W. (1996). Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats. Br. J. Pharmacol., 119, 845850.
  • Azmitia, E.C. & Segal, M. (1978). An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol., 179, 641668.
  • Blier, P. & De Montigny, C. (1987). Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse, 1, 470480.
  • Blier, P., Serrano, A. & Scatton, B. (1990). Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine. Synapse, 5, 120133.
  • Bobillier, P., Petitjean, F., Salvert, D., Ligier, M. & Seguin, S. (1975). Differential projections of the nucleus raphe dorsalis and nucleus raphe centralis as revealed by autoradiography. Brain Res., 85, 205210.
  • Bosker, F.J., De Winter, T.Y.C.E., Klompmakers, A.A. & Westenberg, H.G.M. (1996). Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors. J. Neurochem., 66, 25462555.
  • Bosker, F., Klompmakers, A. & Westenberg, H. (1994). Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin and is sensitive to tetro-dotoxin. J. Neurochem., 63, 21652171.
  • Carboni, E. & Dichiara, G. (1989). Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience, 32, 637645.
  • Casanovas, J.M. & Artigas, F. (1996). Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways. J. Neurochem., 67, 19451952.
  • Casanovas, J.M., Lésourd, M. & Artigas, F. (1997). The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. Br. J. Pharmacol., 122, 733741.
  • Ceci, A., Baschirotto, A. & Borsini, F. (1994). The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe neurons in rats is attenuated by lesion of the frontal cortex. Neuropharmacology, 33, 709713.
  • Chazal, G. & Ralston Iii, H.J. (1987). Serotonin-containing structures in the nucleus raphe dorsalis of the cat: an ultrastructural analysis of dendrites, presynaptic dendrites, and axon terminals. J. Comp. Neurol., 259, 317329.
  • Chen, N.H. & Reith, M.E.A. (1994). Effects of locally applied COcaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: a microdialysis study on monoamine interrelationships. J. Neurochem., 63, 17011713.
  • Cheng, C.H.K., Costall, B., Naylor, R.J. & Rudd, J.A. (1993). The effect of 5-HT receptor ligands on the uptake of [3H]5-hydroxytryptamine into rat cortical synaptosomes. Eur. J. Pharmacol., 239, 211214.
  • Corradetti, R., Le Poul, E., Laaris, N., Hamon, M. & Lanfumey, L. (1996). Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro. J. Pharmacol. Exp. Ther., 278, 679688.
  • Cox, R.F., Meller, E. & Waszczak, B.L. (1993). Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists. Synapse, 14, 297304.
  • De Vry, J., Schohe-loop, R., Heine, H.-G., Greuel, J.M., Mauler, F., Schmidt, B., Sommermeyer, H. & Glaser, T. (1998). Characterization of the aminomethylchroman derivative BAY × 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist. J. Pharmacol. Exp. Ther., 284, 10821094.
  • Dichiara, G. (1996). Estimation of in-vivo neurotransmitter release by brain microdialysis: the issue of validity. Behav. Pharmacol., 7, 640657.
  • Dilts, R.P. & Boadle-biber, M.C. (1995). Differential activation of the 5-hydroxytryptamine-containing neurons of the midbrain raphe of the rat in response to randomly presented inescapable sound. Neurosci. Lett., 199, 7880.
  • Fletcher, A., Forster, E.A., Bill, D.J., Brown, G., Cliffe, I.A., Hartley, J.E., Jones, D.E., Mclenachan, A., Stanhope, K.J., Critchley, D.J.P., Childs, K.J., Middlefell, V.C., Lanfumey, L., Corradetti, R., Laporte, A.-M., Gozlan, H., Hamon, M. & Dourish, C.T. (1995). Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav. Brain Res., 73, 337353.
  • Fornal, C.A., Metzler, C.W., Gallegos, R.A., Veasey, S.C., Mccreary, A.C. & Jacobs, B.L. (1996). WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. J. Pharmacol. Exp. Ther., 278, 752762.
  • Forster, E.A., Cliffe, I.A., Bill, D.J., Dover, G.M., Jones, D., Reilly, Y. & Fletcher, A. (1995). A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur. J. Pharmacol., 281, 8188.
  • Gartside, S.E., Mcquade, R. & Sharp, T. (1996). Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo. J. Pharmacol. Exp. Ther., 279, 277283.
  • Gartside, S.E., Umbers, V., Hajós, M. & Sharp, T. (1995). Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol., 115, 10641070.
  • Gozlan, H., Laporte, A.-M., Thibault, S., Schechter, L.E., Bolaños, F. & Hamon, M. (1994). Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain. Neuropharmacology, 33, 423431.
  • Hajós, M., Gartside, S. & Sharp, T. (1995). Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine Naunyn-Schmiedeberg' s. Arch. Pharmacol., 351, 624629.
  • Hamon, M., Bourgoin, S., Gozlan, H., Hall, M.D., Goetz, C., Artaud, F. & Horn, A.S. (1984). Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)-tetralin) in the rat brain. Eur. J. Pharmacol., 100, 263276.
  • Hensler, J.G., Ferry, R.C., Labow, D.M., Kovachich, G.B. & Frazer, A. (1994). Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus. Synapse, 17, 115.
  • Héry, F., Faudon, M. & Ternaux, J.P. (1982). In vivo release of serotonin in two raphe nuclei (raphe dorsalis and magnus) of the cat. Brain Res. Bull., 8, 123129.
  • Heslop, K.E. & Curzon, G. (1994). Depletion and repletion of cortical tissue and dialysate 5-HT after reserpine. Neuropharmacology, 33, 567573.
  • Hillegaart, V., Hjorth, S. & Ahlenius, S. (1990). Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat. J. Neural Transm. [Gen. Sect.], 81, 131145.
  • Imai, H., Steindler, D.A. & Kitai, S.T. (1986). The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J. Comp. Neurol., 243, 363380.
  • Invernizzi, R., Carli, M., Di Clemente, A. & Samanin, R. (1991). Administration of 8-hydroxy-2-(di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity. J. Neurochem., 56, 243247.
  • Jacobs, B.L. & Azmitia, E.C. (1992). Structure and function of the brain serotonin system. Physiol. Rev., 72, 165229.
  • Köhler, C., Chan-palay, V. & Steinbusch, H. (1982). The distribution and origin of serotonin-containing fibers in the septal area: a combined immunohistochemical and fluorescent retrograde tracing study in the rat. J. Comp. Neurol., 209, 91111.
  • Kosofsky, B.E. & Molliver, M.E. (1987). The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse, 1, 153168.
  • Kreiss, D.S. & Lucki, I. (1994). Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther., 269, 12681279.
  • Long, J.B., Youngblood, W.Y. & Kizer, J.S. (1983). Regional differences in the response of serotonergic neurons in rat CNS to drugs. Eur. J. Pharmacol., 88, 8997.
  • Lum, J.T. & Piercey, M.F. (1988). Electrophysiological evidence that spiperone is an antagonist of 5-HT1A receptors in the dorsal raphe nucleus. Eur. J. Pharmacol., 149, 915.
  • Mamounas, L.A. & Molliver, M.E. (1988). Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin P-chloroamphetamine (PCA). Exp. Neurol., 102, 2336.
  • Mamounas, L.A., Mullen, C.A., O'Hearn, E. & Molliver, M.E. (1991). Dual serotonergic projections to the forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. Comp. Neurol., 314, 558586.
  • Martín, F. & Artigas, F. (1992). Simultaneous effects of p-chloroamphetamine, d-fenfluramine, and reserpine on free and stored 5-hydroxytryptamine in brain and blood. J. Neurochem., 59, 11381144.
  • Matos, F.F., Urban, C. & Yocca, F.D. (1996). Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: raphé control of somatodendritic and terminal 5-HT release. J. Neural Transm., 103, 173190.
  • Mcquade, R. & Sharp, T. (1997). Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J. Neurochem., 69, 791796.
  • Meller, E., Goldstein, M. & Bohmaker, K. (1990). Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Mol. Pharmacol., 37, 231237.
  • Norman, A.B. & Creese, I. (1986). Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. Mol. Pharmacol., 30, 96103.
  • Nowak, G., Arnt, J. & Hyttel, J. (1988). EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors. Eur. J. Pharmacol., 153, 309311.
  • Paxinos, G. & Watson, C. (1986). The Rat Brain in Stereotaxic Coordinates. Sydney: Academic Press.
  • Pilc, A. & Vetulani, J. (1990). Pretreatment with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline accelerates the electroshock-induced decrease in density of β-adrenoceptors but not functional downregulation. Neuropharmacology, 29, 469473.
  • Pinto, W. & Battaglia, G. (1993). In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites. Neuro Report, 5, 6164.
  • Raghupathi, R.K., Brousseau, D.A. & Mcgonigle, P. (1996). Time-course of recovery of 5-HT1A receptors and changes in 5-HT1A receptor mRNA after irreversible inactivation with EEDQ. Mol. Brain Res., 38, 233242.
  • Romero, L., Bel, N., Artigas, F., De Montigny, C. & Blier, P. (1996). Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology, 15, 349360.
  • Romero, L., Celada, P. & Artigas, F. (1994). Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/Go proteins in dorsal raphe nucleus. Eur J. Pharmacol., 265, 103106.
  • Sharp, T., Bramwell, S.R., Hjorth, S. & Grahame-smith, D.G. (1989). Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br. J. Pharmacol., 98, 989997.
  • Shore, P.A. & Giachetti, A. (1978).Reserpine: basic and clinical pharmacology. In Handbook of Psychopharmacology, Vol. 10, eds. Iversen, L.L., Iversen, S.D. & Snyder, S.H. pp. 197219. New York: Plenum Press.
  • Sinton, C.M. & Fallon, S.L. (1988). Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor. Eur. J. Pharmacol., 157, 173181.